FRANCE-HEALTH-VIRUS
A researcher deposits a microplate in a plate reader for densitometric analysis during the analyze of the results of the clinical study at Inotrem's laboratory in Vandoeuvre-les-Nancy, eastern France, on February 08, 2021. - The hospital resuscitation service conduct clinical trials with nangibotide of Inotrem, initially developed to fight septic shock but which could have effects on the most severe Covid-19 (novel coronavirus) patients by reducing excess of TREM-1 molecules. (Photo by JEAN-CHRISTOPHE VERHAEGEN / AFP) (Photo by JEAN-CHRISTOPHE VERHAEGEN/AFP via Getty Images)
PURCHASE A LICENCE
How can I use this image?
£275.00
GBP
Getty ImagesFRANCE-HEALTH-VIRUS, News Photo
FRANCE-HEALTH-VIRUS Get premium, high resolution news photos at Getty ImagesProduct #:1231062220
FRANCE-HEALTH-VIRUS Get premium, high resolution news photos at Getty ImagesProduct #:1231062220£375£150
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.TO GO WITH AFP STORY BY MARIE-MORGANE LE MOEL
Credit:
Editorial #:
1231062220
Collection:
AFP
Date created:
08 February, 2021
Upload date:
Licence type:
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_92K9JB
Max file size:
4540 x 3021 px (38.44 x 25.58 cm) - 300 dpi - 3 MB